Quidel Reports 2 Percent Uptick in Q3 Revenues; Acquires MDx Firm AnDiaTec | GenomeWeb

This article has been updated from a previous version to include comments from Quidel's Q3 earnings call.

NEW YORK (GenomeWeb News) — Quidel reported after the close of the market on Wednesday that its third quarter revenues inched up nearly 2 percent year over year as sales of flu products increased but were offset by flagging sales of Strep A and pregnancy lateral flow tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.